Potential role of the alcohol and smoking in the squamous cell carcinoma of the head and neck: Review of the current literature and new perspectives

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 2, 2011, Pages 339-344

  Zygogianni, Anna ^a   Kyrgias, George ^b   Mystakidou, Kyriaki ^a   Antypas, Christos ^a   Kouvaris, John ^a   Papadimitriou, Christos ^c   Armonis, Vassilis ^d   Alkati, Hassan ^e   Kouloulias, Vassilis ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b Thessalia University   (Greece)

^c IASO GENERAL HOSPITAL   (Greece)

^d Oncological Hospital of IKA   (Greece)

^e Syrian Bee Center   (Syrian Arab Republic)

Author keywords

Alcohol consumption; Cancer; Factor interactions; Head and neck; Tobacco smoking

Indexed keywords

EID: 79958821322     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (73)

1. Allison P, Locker D, Feine JS, et al (1998). The role of diagnostic delays in the prognosis of oral cancer: a review of the literature. Oral Oncol, 34, 161-70.
2. Al-Rajhi N, Khafaga Y, El-Husseiny J, et al (2000). Early stage carcinoma of oral tongue: prognostic factors for local control and survival. Oral Oncol, 36, 508-14.
3. Andrews E, Seaman WT, Webster-Cyriaque J (2009). Webster-Cyriaque, Oropharyngeal carcinoma in non smokers and non drinkers: a role for HPV. Oral Oncol, 45, 486-91.
4. Asakage T, Yokoyama A, Haneda T, et al (2007). Genetic polymorphisms of alcohol and aldehyde dehydrogenases, and drinking, smoking and diet in Japanese men with oral and pharyngeal squamous cell carcinoma. Carcinogenesis, 28, 865-74.
5. Baan R, Straif K, Grosse Y, et al (2007). Carcinogenicity of alcoholic beverages. Lancet Oncol, 8, 292-3.
6. th ed.), lange medical books/ McGraw-Hill, New York, 282-29.
7. Blot WJ, McLaughlin JK, Winn DM, et al (1988). Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res, 48, 3282-7.
8. Bouchardy C, Hirvonen A, Coutelle C, et al (2000). Role of alcohol dehydrogenase 3 and cytochrome P-4502E1 genotypes in susceptibility to cancers of the upper aerodigestive tract. Int J Cancer, 87, 734-40.
9. Bosron WF, Li TK (1986). Genetic polymorphism of human liver alcohol and aldehyde dehydrogenases, and their relationship to alcohol metabolism and alcoholism. Hepatology, 6, 502-10.
10. Brennan P, Lewis S, Hashibe M, et al (2004). Pooled analysis of alcohol dehydrogenase genotypes and head and neck cancer: a HuGE review. Am J Epidemiol, 159, 1-16.
11. Burling TA, Ziff DC (1988). Tobacco smoking: a comparison between alcohol and drug abuse inpatients. Addict Behav, 13, 185-90.
12. Capaccio P, Ottaviani F, Cuccarini V, et al (2005). Association between methylenetetrahydrofolate reductase polymorphisms, alcohol intake and oropharyngolaryngeal carcinoma in northern Italy. J Laryngol Otol, 119, 371-6.
13. Chen J, Giovannucci E, Kelsey K, et al (1996). A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res, 56, 4862-4.
14. Chen YJ, Chen C, Wu DC, et al (2006). Interactive effects of lifetime alcohol consumption and alcohol and aldehyde dehydrogenase polymorphisms on esophageal cancer risks. Int J Cancer, 119, 2827-31.
15. Chi AC, Appleton K, Henriod JB, et al (2009). Differential induction of CYP1A1 and CYP1B1 by benzo[a]pyrene in oral squamous cell carcinoma cell lines and by tobacco smoking in oral mucosa. Oral Oncol, 45, 980-5.
16. Choi JY, Abel J, Neuhaus T, et al (2003). Role of alcohol and genetic polymorphisms of CYP2E1 and ALDH2 in breast cancer development. Pharmacogenetics, 13, 67-72.
17. Dahlstrom KR, Adler-Storthz K, Etzel CJ, et al (2003), Human papillomavirus type 16 infection and squamous cell carcinoma of the head and neck in never-smokers: a matched pair analysis. Clin Cancer Res, 9, 2620-6.
18. Di Franza JR, Guerrera MP (1990). Alcoholism and smoking. J Stud Alcohol, 51, 130-5.
19. Do KA, Johnson MM, Doherty DA, et al (2003). Second primary tumors in patients with upper aerodigestive tract cancers: joint effects of smoking and alcohol (United States). Cancer Causes Control, 14, 131-8.
20. Druesne-Pecollo N, Tehard B, Mallet Y, et al (2009). Hercberg S and Latino-Martel P, alcohol and genetic polymorphisms: effect on risk of alcohol-related cancer. Lancet Oncol, 10, 173-80.
21. D'Souza G, Kreimer AR, Viscidi R, et al (2007). Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med, 356, 1944-56.
22. Gao CM, Takezaki T, Wu JZ, et al (2007). CYP2E1 Rsa I polymorphism impacts on risk of colorectal cancer association with smoking and alcohol drinking. World J Gastroenterol, 13, 5725-30.
23. Gattá GJF, De Carvalho MB, Siraque MS, et al (2006). Genetic polymorphisms of CYP1A1, CYP2E1, GSTM1, and GSTT1 associated with head and neck cancer. Head Neck, 28, 819-26.
24. Hashibe M, Boffetta P, Zaridze D, et al (2006). Evidence for an important role of alcohol- and aldehyde-metabolizing genes in cancers of the upper aerodigestive tract. Cancer Epidemiol Biomarkers Prev, 15, 696-703.
25. Hashibe M, McKay JD, Curado MP, et al (2008). Multiple ADH genes are associated with upper aerodigestive cancers Nat Genet, 40, 707-9.
26. Henning S, Cascorbi I, Munchow B, et al (1999). Association of arylamine N-acetyltransferases NAT1 and NAT2 genotypes to laryngeal cancer risk. Pharmacogenetics, 9, 103-11.
27. Herrero R, Castellsague X, Pawlita M (2003). Human papillomavirus and oral cancer: the international agency for research on cancer multicenter study. J Natl Cancer Inst, 95, 1772-83.
28. Hildesheim A, Anderson LM, Chen CJ, et al (1997). CYP2E1 genetic polymorphisms and risk of nasopharyngeal carcinoma in Taiwan. J Natl Cancer Inst, 89, 1207-12.
29. Hiraki A, Matsuo K, Wakai K, et al (2007). Gene-gene and gene-environment interactions between alcohol drinking habit and polymorphisms in alcohol-metabolizing enzyme genes and the risk of head and neck cancer in Japan. Cancer Sci, 98, 1087-91.
30. Hoog JO, Heden LO, Larsson K, et al (1986). The gamma 1 and gamma 2 subunits of human liver alcohol dehydrogenase, cDNA structures, two amino acid replacements, and compatibility with changes in the enzymatic properties. Eur J Biochem, 159, 215-8.
31. Institut national du cancer and réseau national alimentation cancer recherche (2007). Alcool et risque de cancers. Etat des lieux des données scientifiques et recommandations de santé publique, INCa, Boulogne-Billancourt.
32. Kim DH, Ahn YO, Lee BH, et al (2004). Methylenetetrahydrofolate reductase polymorphism, alcohol intake, and risks of colon and rectal cancers in Korea. Cancer Lett, 216, 199-205.
33. Kohn CS, Tsoh JY, Weisner CM, et al (2003). Changes in smoking status among substance abusers: baseline characteristics and abstinence from alcohol and drugs at 12-month follow-up. Drug Alcohol Depend, 69, 61-71.
34. Koutsky LA, Ault KA, Wheeler CM, et al (2002) A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med, 347, 1645-51.
35. La Vecchia C, Lucchini F, Negri E, et al (2004). Trends in oral cancer mortality in Europe. Oral Oncol, 40, 433-9.
36. Lee HS, Yoon JH, Kamimura S, et al (1997). Lack of association of cytochrome P450 2E1 genetic polymorphisms with the risk of human hepatocellular carcinoma. Int J Cancer, 71, 737-40.
37. Le Marchand L, Wilkens LR, Kolonel LN, et al (2005). The MTHFR C677T polymorphism and colorectal cancer: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev, 14, 1198-203.
38. Lieber CS (1997). Cytochrome P-4502E1: its physiological and pathological role. Physiol Rev, 77, 517-44.
39. Lo WL, Kao SY, Chi LY, et al (2003). Outcomes of oral squamous cell carcinoma in Taiwan after surgical therapy: factors affecting survival. J Oral Maxillofac Surg, 61, 751-8.
40. Ma J, Stampfer MJ, Giovannucci E, et al (1997). Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res, 57, 1098-102.
41. Marks JL, Hill EM, Pomerleau CS, et al (1997). Nicotine dependence and withdrawal in alcoholic and nonalcoholic ever-smokers. J Subst Abuse Treat, 14, 521-7.
42. Matsuo K, Hamajima N, Shinoda M, et al (2001). Gene-environment interaction between an aldehyde dehydrogenase-2 (ALDH2) polymorphism and alcohol consumption for the risk of esophageal cancer. Carcinogenesis, 22, 913-6.
43. Miller NS, Gold MS (1998). Comorbid cigarette and alcohol addiction: epidemiology and treatment. J Addict Dis, 17, 55-66.
44. Miyazaki M, Ohno S, Futatsugi M, et al (2002). The relation of alcohol consumption and cigarette smoking to the multiple occurrence of esophageal dysplasia and squamous cell carcinoma. Surgery, 131, S7-13.
45. Morita M, Saeki H, Mori M, et al (2002). Risk factors for esophageal cancer and the multiple occurrence of carcinoma in the upper aerodigestive tract. Surgery, 131, S1-6.
46. O-charoenrat P, Pillai G, Patel S, et al (2003). Tumor thickness predicts cervical nodal metastases and survival in early oral tongue cancer. Oral Oncol, 39, 386-90.
47. Peters ES, McClean MD, Liu M, et al (2005). The ADH1C polymorphism modifies the risk of squamous cell carcinoma of the head and neck associated with alcohol and tobacco use. Cancer Epidemiol Biomarkers Prev, 14, 476-82.
48. Petti S (2008). Lifestyle risk factors for oral cancer. Oral Oncol, 45, 340-50.
49. Pintos J, Black MJ, Sadeghi N, et al (2008). Human papillomavirus infection and oral cancer: a case-control study in Montreal, Canada. Oral Oncol, 44, 242-50
50. Quertemont E (2004). Genetic polymorphism in ethanol metabolism: acetaldehyde contribution to alcohol abuse and alcoholism. Mol Psychiatry, 9, 570-81.
51. Ribeiro KCB, Kowalski LP, MRDO (2003). Perioperative complications, comorbidities, and survival in oral or oropharyngeal cancer. Arch Otolaryngol Head Neck Surg, 129, 219-28.
52. Risch A, Ramroth H, Raedts V, et al (2003). Laryngeal cancer risk in Caucasians is associated with alcohol and tobacco consumption but not modified by genetic polymorphisms in class I alcohol dehydrogenases ADH1B and ADH1C, and glutathione-S-transferases GSTM1 and GSTT1. Pharmacogenetics, 13, 225-30.
53. Rodriquez M, Acha A, Ruesga M, et al (2007). Loss of expression of DNA repair enzyme MGMT in oral leukoplakia and early oral squamous cell carcinoma. a prognostic tool? Cancer Lett, 245, 263-8.
54. Seitz HK, Stickel F (2007). Molecular mechanisms of alcoholmediated carcinogenesis. Nat Rev Cancer, 7, 599-612.
55. Seitz HK, Stickel F (2010). Acetaldehyde as an underestimated risk factor for cancer development: role of genetics in ethanol metabolism. Gene Nutr, 5, 121-8.
56. Slattery ML, Potter JD, Samowitz W, et al (1999). Methylenetetrahydrofolate reductase, diet, and risk of colon cancer. Cancer Epidemiol Biomarkers Prev, 8, 513-8.
57. Suzuki T, Matsuo K, Hasegawa Y, et al (2007). One-carbon metabolism-related gene polymorphisms and risk of head and neck squamous cell carcinoma: case-control study. Cancer Sci, 98, 1439-46.
58. Talamini R, Bosetti C, La Vecchia C, et al (2002). Combined effect of tobacco and alcohol on laryngeal cancer risk: a case-control study. Cancer Causes Control, 13, 957-64.
59. U.S. Department of Health and Human Services, (2000). Oral health in America: a report of the Surgeon General-executive summary, US department of health and human services, national institute of dental and craniofacial research, national institutes of health, rockville (MD), 1-13.
60. Vaillant GE, Schnurr PP, Baron JA, et al (1991). A prospective study of the effects of cigarette smoking and alcohol abuse on mortality. J Gen Intern Med, 6, 299-304.
61. Villard PH, Seree EM, Re JL, et al (1998). Effects of tobacco smoke on the gene expression of the Cyp1a, Cyp2b, Cyp2e, and Cyp3a subfamilies in mouse liver and lung: relation to single strand breaks of DNA. Toxicol Appl Pharmacol, 148, 195-204.
62. Wallstrom P, Frenkel K, Wirfalt E, et al (2003). Antibodies against 5-hydroxymethyl-2'-deoxyuridine are associated with lifestyle factors and GSTM1 genotype: a report from the malmo diet and cancer cohort. Cancer Epidemiol Biomarkers Prev, 12, 444-51.
63. Warnakulasuriya S (2008). Global epidemiology of oral and oropharyngeal cancer. Oral Oncol, 45, 309-16.
64. World Cancer Research Fund and American Institute for Cancer Research (2007). Food, nutrition, physical Activity, and the prevention of cancer: a global perspective, AICR, Washington DC.
65. World Health Organization (2003). The World Oral Health Report 2003, World Health Organization, Geneva, 6-7.
66. Xavier Bosch, Silvia de Sanjosé (2007). The epidemiology of human papillomavirus infection and cervical cancer. Dis Markers, 23, 213-27.
67. Yang CX, Matsuo K, Ito H, et al (2005). Esophageal cancer risk by ALDH2 and ADH2 polymorphisms and alcohol consumption: exploration of gene-environment and genegene interactions. Asian Pac J Cancer Prev, 6, 256-62.
68. Yang SJ, Wang HY, Li XQ, et al (2007). Genetic polymorphisms of ADH2 and ALDH2 association with esophageal cancer risk in southwest China. World J Gastroenterol, 13, 5760-4.
69. Yokoyama A, Kato H, Yokoyama T, et al (2002). Genetic polymorphisms of alcohol and aldehyde dehydrogenases and glutathione S-transferase M1 and drinking, smoking, and diet in Japanese men with esophageal squamous cell carcinoma. Carcinogenesis, 23, 1851-9.
70. Yu MW, Gladek-Yarborough A, Chiamprasert S, et al (1995). Cytochrome P450 2E1 and glutathione s-transferase M1 polymorphisms and susceptibility to hepatocellular carcinoma. Gastroenterology, 109, 1266-73.
71. Zavras AI, Wu T, Laskaris G, et al (2002). Interaction between a single nucleotide polymorphism in the alcohol dehydrogenase 3 gene, alcohol consumption and oral cancer risk. Int J Cancer, 97, 526-30.
72. Znaor A, Brennan P, Gajalakshmi V, et al (2003). Independent and combined effects of tobacco smoking, chewing and alcohol drinking on the risk of oral, pharyngeal and esophageal cancers in Indian men. Int J Cancer, 105, 681-6.
73. Zygogianni A, Kyrgias G, Karakitsos P, et al (2011). Oral squamous cell cancer: early detection and the role of alcohol and smoking. Head Neck Oncol, 3, 2.